MeSH term
Frequency | Condition_Probility | Animals | 22 | 0.0 |
Comparative Study | 10 | 0.0 |
Factor IX/*genetics | 14 | 51.0 |
Female | 32 | 0.0 |
Hemophilia B/genetics | 2 | 40.0 |
Humans | 63 | 0.0 |
Introns/genetics | 2 | 0.0 |
Male | 28 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 6 | 0.0 |
DNA/genetics | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Mutation | 5 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Infant | 3 | 0.0 |
Mice | 13 | 0.0 |
Research Support, Non-U.S. Gov't | 35 | 0.0 |
Germ-Line Mutation/*genetics | 2 | 1.0 |
*Software | 2 | 3.0 |
Cell Differentiation | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Genetic Markers | 8 | 0.0 |
Hybrid Cells | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*X Chromosome | 14 | 1.0 |
Phenotype | 3 | 0.0 |
Pregnancy | 4 | 0.0 |
Adolescent | 6 | 0.0 |
Adult | 7 | 0.0 |
*Germ-Line Mutation | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Hemophilia B/*genetics | 5 | 55.0 |
Point Mutation | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Aged | 2 | 0.0 |
Middle Aged | 6 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Plasmids | 3 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 4 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 8 | 0.0 |
Protein Conformation | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Flow Cytometry | 2 | 0.0 |
*Linkage (Genetics) | 8 | 0.0 |
X Chromosome/*genetics | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
DNA Probes | 4 | 0.0 |
Species Specificity | 2 | 0.0 |
Factor IX/genetics | 7 | 33.0 |
Models, Genetic | 2 | 0.0 |
Lod Score | 3 | 0.0 |
Pedigree | 12 | 0.0 |
*Genes, Structural | 2 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Japan | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Cell Line | 7 | 0.0 |
Chromosome Banding | 3 | 0.0 |
Linkage (Genetics) | 7 | 0.0 |
Fragile X Syndrome/*diagnosis/genetics | 2 | 28.0 |
*Heterozygote Detection | 4 | 3.0 |
Binding Sites | 3 | 0.0 |
Isoelectric Focusing | 2 | 0.0 |
Factor VIII/*genetics | 2 | 5.0 |
Risk | 3 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Alleles | 2 | 0.0 |
Hamsters | 3 | 0.0 |
*Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
Fragile X Syndrome/*genetics | 4 | 2.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Sex Chromosome Aberrations/*genetics | 6 | 9.0 |
Electrophoresis | 2 | 0.0 |
*Genetic Markers | 4 | 1.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Pyelonephritis/microbiology | 2 | 50.0 |
Serotyping | 2 | 0.0 |
Urinary Tract Infections/*microbiology | 3 | 27.0 |
DNA/analysis | 2 | 0.0 |
Fragile X Syndrome/diagnosis/*genetics | 2 | 15.0 |
DNA/*genetics | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
Immunization | 2 | 0.0 |
Antigens, Bacterial/*analysis | 2 | 11.0 |
Fimbriae, Bacterial/*immunology | 2 | 22.0 |
Immunoelectrophoresis, Two-Dimensional | 2 | 1.0 |
English Abstract | 3 | 0.0 |
O Antigens | 2 | 20.0 |
